ARTICLE
14 December 2023

The Week In Weed: December 8, 2023

SS
Seyfarth Shaw LLP
Contributor
With more than 900 lawyers across 18 offices, Seyfarth Shaw LLP provides advisory, litigation, and transactional legal services to clients worldwide. Our high-caliber legal representation and advanced delivery capabilities allow us to take on our clients’ unique challenges and opportunities-no matter the scale or complexity. Whether navigating complex litigation, negotiating transformational deals, or advising on cross-border projects, our attorneys achieve exceptional legal outcomes. Our drive for excellence leads us to seek out better ways to work with our clients and each other. We have been first-to-market on many legal service delivery innovations-and we continue to break new ground with our clients every day. This long history of excellence and innovation has created a culture with a sense of purpose and belonging for all. In turn, our culture drives our commitment to the growth of our clients, the diversity of our people, and the resilience of our workforce.
Welcome back to The Week in Weed, your Friday look at what's happening in the world of legalized marijuana. This week, we have an update on Ohio...
Worldwide Cannabis & Hemp
To print this article, all you need is to be registered or login on Mondaq.com.

Welcome back to The Week in Weed, your Friday look at what's happening in the world of legalized marijuana. This week, we have an update on Ohio, where legislators are re-writing the cannabis initiative language. We check in on Alabama, to see how medical marijuana licensing is going. Then, we travel overseas to Germany, where there seems to be a delay in legalization. We bring to your attention that Chris Palmese has a speaking engagement coming up. And finally, we have a celebrity who *is* endorsing CBD.

OHIO

Last month, voters in Ohio voted to legalize cannabis for adult-use. If you haven't followed the fate of ballot initiatives very closely in the past, you may have thought, "well now that's settled." Those of us who write weekly cannabis blogs know the vote is often not the end of the story. And so it is here in the Buckeye State. As we noted a couple of weeks ago, many of the state's politicians, including the Governor, were opposed to legalization, and we wondered how they would go about writing a law. Well, with the deadline to do so fast approaching (by the time you read this, the deadline will have passed), the legislature has been busy. A Senate committee proposed a law that would have, among other things, delayed retail sales for a year, but now that same panel has reversed that decision and, again among other things, looks to approve retails sales in as soon as 90 days. The state's House still needs to vote on this – we'll let you know how it all shakes out next week!

ALABAMA

Another week, another update on medical cannabis licensing in Alabama. Last week, we saw applicants go before the state's cannabis commission for the third time. And, again for the third time, we now note that the state has issued licenses. Applicants have until mid-month to submit their licensing fees. Let's hope this marks the end of this story, because the blogging community is running out of adages (third time's the charm!) to describe this situation.

GERMANY

Cannabis legalization is not only an American story. Countries in Europe are working their way through this process as well. Take Germany, for example. The country has the largest economy in Europe, and legalization would be a major step for the international cannabis industry. There have been different bills proposed; the one that's currently under discussion would go into effect in April 2024. The latest news is that a vote that was planned for this month will now be put off until next year. Advocates of the legislation believe this will still allow enough time to meet the April date, provided the vote takes place in January. Further bulletins as events warrant.

SEYFARTH ATTORNEY TO SPEAK

If you'll be attending Bisnow's Tri-State Cannabis & Real Estate Conference in New York City on December 14, check out our own Chris Palmese's panel on "Managing Retail, Site Selection & Creating Compliant Spaces." The discussion will center around the challenges and opportunities in finding the right space to set up shop.

AND FINALLY

We've reported pretty often on cannabis companies faking celebrity endorsements for their products. We take a dim view of this practice – if your product is good, you don't need to lie about who uses it. Today, we're highlighting a celebrity who is all in on CBD. If you're thinking it's Snoop Dogg, you're close! It's Martha Stewart, who has a new line of CBD gummies available.

Be well and we'll see you next week!

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

ARTICLE
14 December 2023

The Week In Weed: December 8, 2023

Worldwide Cannabis & Hemp
Contributor
With more than 900 lawyers across 18 offices, Seyfarth Shaw LLP provides advisory, litigation, and transactional legal services to clients worldwide. Our high-caliber legal representation and advanced delivery capabilities allow us to take on our clients’ unique challenges and opportunities-no matter the scale or complexity. Whether navigating complex litigation, negotiating transformational deals, or advising on cross-border projects, our attorneys achieve exceptional legal outcomes. Our drive for excellence leads us to seek out better ways to work with our clients and each other. We have been first-to-market on many legal service delivery innovations-and we continue to break new ground with our clients every day. This long history of excellence and innovation has created a culture with a sense of purpose and belonging for all. In turn, our culture drives our commitment to the growth of our clients, the diversity of our people, and the resilience of our workforce.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More